Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Teva Pounces On US Revlimid Opportunity With Four Strength-Offering
Israeli Firm Has Partnered With Natco; December 2015 Settlement Provides For Entry
07 Mar 2022
•
By
Dean Rudge
Teva and Natco have waited more than six years for the opportunity • Source: Olivier Le Moal / Alamy Stock Photo
More from Generics
More from Products